Private Wealth Management Group’s Integra LifeSciences IART Stock Holding History

Private Wealth Management Group’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-246	Closed	-$3.53K	–	1503
2025 Q3	$3.53K	Hold	246	–	–	﹤0.01%	924
2025 Q2	$3.02K	Sell	246 -31	-11%	-$450	﹤0.01%	958
2025 Q1	$6.09K	Hold	277	–	–	﹤0.01%	646
2024 Q4	$6.28K	Hold	277	–	–	﹤0.01%	650
2024 Q3	$5.03K	Buy	277 +62	+29%	+$1.44K	﹤0.01%	737
2024 Q2	$6.27K	Buy	215 +161	+298%	+$4.78K	﹤0.01%	619
2024 Q1	$1.92K	Buy	54 +36	+200%	+$1.44K	﹤0.01%	992
2023 Q4	$784	Buy	+18	New	+$708	﹤0.01%	1354

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Private Wealth Management Group's IART Position: Q4 2025 in Review

Private Wealth Management Group sold out of Integra LifeSciences (IART) in Q4 2025, closing a stake of 246 shares — an estimated $3.53K sold.

Private Wealth Management Group first reported a position in IART in Q4 2023 and held it in 8 quarters. The position peaked at $6.28K in Q4 2024. 204 funds tracked by Wall St. Rank hold IART as of Q4 2025.

Private Wealth Management Group reported no remaining Integra LifeSciences position as of Q4 2025 after selling out during the quarter.
Private Wealth Management Group sold 246 Integra LifeSciences shares in Q4 2025, an estimated $3.53K.
Private Wealth Management Group first reported a position in Integra LifeSciences in Q4 2023 and held it in 8 quarters.
Private Wealth Management Group's Integra LifeSciences position peaked at $6.28K in Q4 2024.
204 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2025.

Based on Private Wealth Management Group's 13F filing for Q4 2025, filed 23 Jan 2026.